FOXO TECHNOLOGIES INC. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
FOXO TECHNOLOGIES INC. (FOXO) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits of $2.74 million as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits · last filed 2026-04-15
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $2.74M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $2.72M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $482.00K.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $3.82M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits |
|---|---|
| 2025-12-31 | $2.74M 10-K · filed 2026-04-15 |
| 2024-12-31 | $2.72M 10-K · filed 2026-04-15 |
| 2023-12-31 | $482.00K 10-K · filed 2024-06-06 |
| 2022-12-31 | $3.82M 10-K · filed 2024-06-06 |
| 2021-12-31 | $38.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |